Go Pro

Varex Imaging (VREX) Competitors

Varex Imaging logo
$18.49 -0.01 (-0.05%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$18.50 +0.01 (+0.03%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

VREX vs. BRBR, NVST, ATRC, NVCR, and INSP

Should you buy Varex Imaging stock or one of its competitors? Varex Imaging's main competitors and comparable companies include BellRing Brands (BRBR), Envista (NVST), AtriCure (ATRC), NovoCure (NVCR), and Inspire Medical Systems (INSP). Companies are selected based on similarities in market, industry, and size.

How does Varex Imaging compare to BellRing Brands?

BellRing Brands (NYSE:BRBR) and Varex Imaging (NASDAQ:VREX) are related small-cap companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership.

BellRing Brands has higher revenue and earnings than Varex Imaging. BellRing Brands is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BellRing Brands$2.32B0.54$216.20M$1.427.57
Varex Imaging$844.60M0.92-$70.30M$0.5235.56

BellRing Brands has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market. Comparatively, Varex Imaging has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market.

BellRing Brands currently has a consensus target price of $19.82, indicating a potential upside of 84.47%. Varex Imaging has a consensus target price of $16.88, indicating a potential downside of 8.73%. Given BellRing Brands' stronger consensus rating and higher probable upside, analysts clearly believe BellRing Brands is more favorable than Varex Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BellRing Brands
1 Sell rating(s)
8 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.44
Varex Imaging
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.83

BellRing Brands has a net margin of 7.28% compared to Varex Imaging's net margin of 2.55%. Varex Imaging's return on equity of 9.19% beat BellRing Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
BellRing Brands7.28% -33.04% 15.63%
Varex Imaging 2.55%9.19%4.13%

95.0% of BellRing Brands shares are owned by institutional investors. 1.5% of BellRing Brands shares are owned by insiders. Comparatively, 4.6% of Varex Imaging shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Varex Imaging had 21 more articles in the media than BellRing Brands. MarketBeat recorded 30 mentions for Varex Imaging and 9 mentions for BellRing Brands. Varex Imaging's average media sentiment score of 0.88 beat BellRing Brands' score of 0.81 indicating that Varex Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BellRing Brands
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Varex Imaging
13 Very Positive mention(s)
3 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

BellRing Brands beats Varex Imaging on 9 of the 16 factors compared between the two stocks.

How does Varex Imaging compare to Envista?

Varex Imaging (NASDAQ:VREX) and Envista (NYSE:NVST) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

In the previous week, Varex Imaging had 27 more articles in the media than Envista. MarketBeat recorded 30 mentions for Varex Imaging and 3 mentions for Envista. Varex Imaging's average media sentiment score of 0.88 beat Envista's score of 0.84 indicating that Varex Imaging is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Varex Imaging
13 Very Positive mention(s)
3 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Envista
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Envista has higher revenue and earnings than Varex Imaging. Varex Imaging is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Varex Imaging$844.60M0.92-$70.30M$0.5235.56
Envista$2.72B1.66$47M$0.5848.35

Varex Imaging presently has a consensus price target of $16.88, indicating a potential downside of 8.73%. Envista has a consensus price target of $29.31, indicating a potential upside of 4.50%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Varex Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Varex Imaging
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.83
Envista
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.50

Envista has a net margin of 3.33% compared to Varex Imaging's net margin of 2.55%. Varex Imaging's return on equity of 9.19% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Varex Imaging2.55% 9.19% 4.13%
Envista 3.33%7.88%4.33%

Varex Imaging has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Envista has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Summary

Envista beats Varex Imaging on 11 of the 15 factors compared between the two stocks.

How does Varex Imaging compare to AtriCure?

Varex Imaging (NASDAQ:VREX) and AtriCure (NASDAQ:ATRC) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Varex Imaging has a net margin of 2.55% compared to AtriCure's net margin of 1.85%. Varex Imaging's return on equity of 9.19% beat AtriCure's return on equity.

Company Net Margins Return on Equity Return on Assets
Varex Imaging2.55% 9.19% 4.13%
AtriCure 1.85%2.34%1.77%

AtriCure has lower revenue, but higher earnings than Varex Imaging. Varex Imaging is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Varex Imaging$844.60M0.92-$70.30M$0.5235.56
AtriCure$534.53M4.22-$11.45M$0.21210.95

Varex Imaging has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, AtriCure has a beta of 1.2, indicating that its share price is 20% more volatile than the broader market.

Varex Imaging presently has a consensus price target of $16.88, suggesting a potential downside of 8.73%. AtriCure has a consensus price target of $48.50, suggesting a potential upside of 9.48%. Given AtriCure's stronger consensus rating and higher possible upside, analysts clearly believe AtriCure is more favorable than Varex Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Varex Imaging
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.83
AtriCure
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.82

In the previous week, Varex Imaging had 24 more articles in the media than AtriCure. MarketBeat recorded 30 mentions for Varex Imaging and 6 mentions for AtriCure. Varex Imaging's average media sentiment score of 0.88 beat AtriCure's score of 0.80 indicating that Varex Imaging is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Varex Imaging
13 Very Positive mention(s)
3 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AtriCure
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.1% of AtriCure shares are owned by institutional investors. 4.6% of Varex Imaging shares are owned by insiders. Comparatively, 4.0% of AtriCure shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

AtriCure beats Varex Imaging on 9 of the 17 factors compared between the two stocks.

How does Varex Imaging compare to NovoCure?

Varex Imaging (NASDAQ:VREX) and NovoCure (NASDAQ:NVCR) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Varex Imaging has higher revenue and earnings than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Varex Imaging$844.60M0.92-$70.30M$0.5235.56
NovoCure$699.19M2.82-$136.23M-$1.30N/A

Varex Imaging presently has a consensus price target of $16.88, indicating a potential downside of 8.73%. NovoCure has a consensus price target of $21.20, indicating a potential upside of 25.07%. Given NovoCure's stronger consensus rating and higher probable upside, analysts plainly believe NovoCure is more favorable than Varex Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Varex Imaging
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.83
NovoCure
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14

In the previous week, Varex Imaging had 25 more articles in the media than NovoCure. MarketBeat recorded 30 mentions for Varex Imaging and 5 mentions for NovoCure. NovoCure's average media sentiment score of 1.42 beat Varex Imaging's score of 0.88 indicating that NovoCure is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Varex Imaging
13 Very Positive mention(s)
3 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NovoCure
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Varex Imaging has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, NovoCure has a beta of 0.97, indicating that its share price is 3% less volatile than the broader market.

84.6% of NovoCure shares are held by institutional investors. 4.6% of Varex Imaging shares are held by insiders. Comparatively, 6.6% of NovoCure shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Varex Imaging has a net margin of 2.55% compared to NovoCure's net margin of -21.25%. Varex Imaging's return on equity of 9.19% beat NovoCure's return on equity.

Company Net Margins Return on Equity Return on Assets
Varex Imaging2.55% 9.19% 4.13%
NovoCure -21.25%-44.00%-15.85%

Summary

Varex Imaging and NovoCure tied by winning 8 of the 16 factors compared between the two stocks.

How does Varex Imaging compare to Inspire Medical Systems?

Varex Imaging (NASDAQ:VREX) and Inspire Medical Systems (NYSE:INSP) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Inspire Medical Systems has a net margin of 15.03% compared to Varex Imaging's net margin of 2.55%. Varex Imaging's return on equity of 9.19% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Varex Imaging2.55% 9.19% 4.13%
Inspire Medical Systems 15.03%8.64%7.45%

Inspire Medical Systems has higher revenue and earnings than Varex Imaging. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Varex Imaging$844.60M0.92-$70.30M$0.5235.56
Inspire Medical Systems$898.74M1.84$145.42M$4.6212.39

Varex Imaging presently has a consensus price target of $16.88, suggesting a potential downside of 8.73%. Inspire Medical Systems has a consensus price target of $68.00, suggesting a potential upside of 18.76%. Given Inspire Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Inspire Medical Systems is more favorable than Varex Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Varex Imaging
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.83
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.10

94.9% of Inspire Medical Systems shares are owned by institutional investors. 4.6% of Varex Imaging shares are owned by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Varex Imaging had 19 more articles in the media than Inspire Medical Systems. MarketBeat recorded 30 mentions for Varex Imaging and 11 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.08 beat Varex Imaging's score of 0.88 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Varex Imaging
13 Very Positive mention(s)
3 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
8 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Varex Imaging has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market.

Summary

Inspire Medical Systems beats Varex Imaging on 12 of the 17 factors compared between the two stocks.

Get Varex Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for VREX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VREX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VREX vs. The Competition

MetricVarex ImagingHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$778.85M$5.95B$7.06B$13.10B
Dividend YieldN/A1.76%2.57%10.45%
P/E Ratio35.5626.22269.0625.28
Price / Sales0.9263.22601.6191.31
Price / Cash4.7733.9270.4850.90
Price / Book1.526.1012.916.24
Net Income-$70.30M$148.67M$3.45B$347.60M
7 Day Performance48.99%1.83%1.10%1.06%
1 Month Performance71.36%3.98%1.32%0.81%
1 Year Performance70.10%9.21%62.43%20.90%

Varex Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VREX
Varex Imaging
2.6177 of 5 stars
$18.49
-0.1%
$16.88
-8.7%
+71.5%$778.85M$844.60M35.562,400
BRBR
BellRing Brands
4.69 of 5 stars
$12.23
-5.5%
$20.97
+71.4%
-71.7%$1.42B$2.32B9.48380
NVST
Envista
1.883 of 5 stars
$27.72
+1.3%
$28.62
+3.2%
+34.5%$4.51B$2.72B67.5812,000
ATRC
AtriCure
4.1914 of 5 stars
$38.79
+0.2%
$48.50
+25.0%
+25.1%$1.97B$569.62M184.341,300
NVCR
NovoCure
3.6195 of 5 stars
$15.77
+2.9%
$21.20
+34.4%
+46.2%$1.83B$655.35MN/A1,605

Related Companies and Tools


This page (NASDAQ:VREX) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners